Trial Profile
A Randomized Clinical Trial to Evaluate the Effects of High Dose Statin and Niacin Therapy on Excised Plaque Biomarkers in Patients Undergoing Carotid Endarterectomy (CEA)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Niacin (Primary) ; Simvastatin (Primary)
- Indications Atherosclerosis
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- Acronyms MCAT
- Sponsors Merck & Co; Merck Sharp & Dohme
- 23 Oct 2012 Planned number of patients changed from 100 to 138.
- 18 Apr 2012 Actual patient number changed from 96 to 100 as reported by ClinicalTrials.gov.
- 12 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.